Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3,6-Month, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Two Doses of Asoprisnil Versus Placebo in Subjects With Uterine Leiomyomata

NCT00152256 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00152256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00152256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3,6-Month, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Two Doses of Asoprisnil Versus Placebo in Subjects With Uterine Leiomyomata
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2003
Completion date
February 28, 2005
Enrollment
239 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fibroid uterus, leiomyoma, menorrhagia, metrorrhagia, uterine fibroids